1m7q
From Proteopedia
Line 1: | Line 1: | ||
[[Image:1m7q.jpg|left|200px]] | [[Image:1m7q.jpg|left|200px]] | ||
- | + | <!-- | |
- | + | The line below this paragraph, containing "STRUCTURE_1m7q", creates the "Structure Box" on the page. | |
- | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
- | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
- | | | + | or leave the SCENE parameter empty for the default display. |
- | | | + | --> |
- | + | {{STRUCTURE_1m7q| PDB=1m7q | SCENE= }} | |
- | + | ||
- | + | ||
- | }} | + | |
'''Crystal structure of p38 MAP kinase in complex with a dihydroquinazolinone inhibitor''' | '''Crystal structure of p38 MAP kinase in complex with a dihydroquinazolinone inhibitor''' | ||
Line 42: | Line 39: | ||
[[Category: Wang, Z.]] | [[Category: Wang, Z.]] | ||
[[Category: Zaller, D M.]] | [[Category: Zaller, D M.]] | ||
- | [[Category: | + | [[Category: Atp-binding domain]] |
- | [[Category: | + | [[Category: Inhibitor]] |
- | [[Category: | + | [[Category: Serine/threonine kinase]] |
- | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 00:44:15 2008'' | |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + |
Revision as of 21:44, 2 May 2008
Crystal structure of p38 MAP kinase in complex with a dihydroquinazolinone inhibitor
Overview
The development of potent, orally bioavailable (in rat) and selective dihydroquinazolinone inhibitors of p38alpha MAP kinase is described. These analogues are hybrids of a pyridinylimidazole p38alpha inhibitor reported by Merck Research Laboratories and VX-745. Optimization of the C-5 phenyl and the C-7 piperidinyl substituents led to the identification of 15i which gave excellent suppression of TNF-alpha production in LPS-stimulated whole blood (IC(50)=10nM) and good oral exposure in rats (F=68%, AUCn PO=0.58 microM h).
About this Structure
1M7Q is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase., Stelmach JE, Liu L, Patel SB, Pivnichny JV, Scapin G, Singh S, Hop CE, Wang Z, Strauss JR, Cameron PM, Nichols EA, O'Keefe SJ, O'Neill EA, Schmatz DM, Schwartz CD, Thompson CM, Zaller DM, Doherty JB, Bioorg Med Chem Lett. 2003 Jan 20;13(2):277-80. PMID:12482439 Page seeded by OCA on Sat May 3 00:44:15 2008
Categories: Homo sapiens | Single protein | Cameron, P M. | Doherty, J B | Hop, C E.C A. | Keefe, S J.O. | Liu, L. | Neill, E A.O. | Nichols, E A. | Patel, S B. | Pivnichny, J V. | Scapin, G. | Schmatz, D M. | Schwartz, C D. | Singh, S. | Stelmach, J E. | Thompson, C M. | Wang, Z. | Zaller, D M. | Atp-binding domain | Inhibitor | Serine/threonine kinase